- Home
- BRAG vs LITS Comparison
BRAG vs LITS Comparison
Compare BRAG & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRAG | LITS |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | Canada | United States |
| Employees | N/A | 4 |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.5M | 40.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRAG | LITS |
|---|---|---|
| Price | $1.53 | $1.19 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 25.7K | ★ 338.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.63 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.46 | $0.95 |
| 52 Week High | $4.82 | $3.03 |
Technical Indicators
Market Signals| Indicator | BRAG | LITS |
|---|---|---|
| Relative Strength Index (RSI) | 29.22 | 50.92 |
| Support Level | N/A | $1.17 |
| Resistance Level | $2.77 | $1.65 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 12.99 | 77.01 |
Price Performance
Historical ComparisonAbout BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.
About LITS Lite Strategy Inc.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.